Lundbeck
HLUN-B.CO
#2246
Rank
โ‚น790.34 B
Marketcap
โ‚น796.60
Share price
0.80%
Change (1 day)
25.00%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): โ‚น29.01

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น71.43. In 2022 the company made an earnings per share (EPS) of โ‚น25.27 a decrease over its 2021 EPS that were of โ‚น56.74.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น29.0114.81%
2022โ‚น25.27-55.47%
2021โ‚น56.74-51.83%
2020โ‚น117.79-28.01%
2019โ‚น163.62-44.08%
2018โ‚น292.5951.94%
2017โ‚น192.57126.64%
2016โ‚น84.97-120.84%
2015-โ‚น407.735622.18%
2014-โ‚น7.13-110.03%
2013โ‚น71.02-28.08%
2012โ‚น98.74-52.1%
2011โ‚น206.13-1.31%
2010โ‚น208.8815.61%
2009โ‚น180.67